You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

CLINICAL TRIALS PROFILE FOR LOFEXIDINE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Lofexidine Hydrochloride

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000345 ↗	Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10	Completed	National Institute on Drug Abuse (NIDA)	Phase 1	1996-04-01	The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.
NCT00000354 ↗	Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3	Completed	University of Pennsylvania	Phase 1	1996-07-01	The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000354 ↗	Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3	Completed	National Institute on Drug Abuse (NIDA)	Phase 1	1996-07-01	The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000358 ↗	Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7	Completed	University of Pennsylvania	Phase 1	1969-12-31	The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000358 ↗	Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7	Completed	National Institute on Drug Abuse (NIDA)	Phase 1	1969-12-31	The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Lofexidine Hydrochloride

Condition Name

Chart
Table

Condition Name for Lofexidine Hydrochloride
Intervention	Trials
Opioid Withdrawal	8
Opioid-Related Disorders	6
Opioid Dependence	5
Opioid-use Disorder	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Lofexidine Hydrochloride
Intervention	Trials
Opioid-Related Disorders	19
Substance Withdrawal Syndrome	14
Substance-Related Disorders	4
Disease	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Lofexidine Hydrochloride

Trials by Country

Map
Table

Trials by Country for Lofexidine Hydrochloride
Location	Trials
United States	90
Singapore	1
Egypt	1
Israel	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Lofexidine Hydrochloride
Location	Trials
New York	9
Texas	9
Maryland	8
Pennsylvania	7
California	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Lofexidine Hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Lofexidine Hydrochloride
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	5
Phase 2/Phase 3	2
[disabled in preview]	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Lofexidine Hydrochloride
Clinical Trial Phase	Trials
Completed	29
Recruiting	7
Not yet recruiting	4
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lofexidine Hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for Lofexidine Hydrochloride
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	28
US WorldMeds LLC	19
New York State Psychiatric Institute	4
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Lofexidine Hydrochloride
Sponsor	Trials
NIH	29
Other	27
Industry	24
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.